The patients were T2DM, and about 2/3 received statins, and nearly 1/3 insulin; all had previously undergone coronary calcium score (CCS) screening using CT and NaF PET/CT as baseline assessments for a trial on the arterial effects of vitamin K1 and colchicine in subjects with diabetes (see also [47]). This evidence concerns the gene INS and type 2 diabetes mellitus.